US 8,114,833 · Application 11/435,977 · Granted Feb 14, 2012
US 8,114,833
Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
Estimated expiration
September 12, 2026
Expired 2 days ago
- Could not fetch continuity data for application PCTDK2004000792: Resource not found (404)
- Application 11667040 has not been granted a patent number
Earliest effective filing
Nov 18, 2004
+ 20 years
Nov 18, 2024
PTA +663d
Sep 12, 2026
TD applied
Sep 12, 2026
Final
Sep 12, 2026
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- May 17, 2006
- Earliest effective filing
- November 18, 2004
- Issue date
- February 14, 2012
- PTA
- +663 days
- Base expiry (before PTA)
- November 18, 2024
November 18, 2004 + 20 years = November 18, 2024 + 663 PTA days = September 12, 2026
- Continuation of application PCTDK2004000792, filed Nov 18, 2004
Terminal disclaimers
TD caps expiration to September 12, 2026
US 6,683,204· Application 10/070,393Lapsed
Method for producing monoisocyanates and oligoisocyanates
Expired: maintenance fee lapse.
- Filing date
- Mar 4, 2002
- Earliest effective filing
- Mar 4, 2002
- Issue date
- Jan 27, 2004
- PTA
- 0 days
- Calculated expiration
- —
US 8,114,833· Application 11/435,977(from application 11/435,977)Capping patent
Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
- Filing date
- May 17, 2006
- Earliest effective filing
- Nov 18, 2004
- Issue date
- Feb 14, 2012
- PTA
- +663 days
- Calculated expiration
- Sep 12, 2026
Continuation of PCTDK2004000792, filed Nov 18, 2004
Nov 18, 2004 + 20y + 663d PTA = Sep 12, 2026
US APP:11667040(from application 11/667,040)
Could not resolve calculation details
US 7,595,293· Application 11/244,497(from application 11/244,497)Lapsed
Stable pharmaceutical compositions
Expired: maintenance fee lapse.
- Filing date
- Oct 3, 2005
- Earliest effective filing
- Oct 3, 2005
- Issue date
- Sep 29, 2009
- PTA
- 0 days
- Calculated expiration
- —
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 11/435,977 · US 8,114,833
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 8,114,833: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US8114833Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.